These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 231196)

  • 1. Depolarization-induced inhibition of cyclic AMP accumulation: cholinergic-adrenergic antagonism in murine atria.
    Brown JH
    Mol Pharmacol; 1979 Nov; 16(3):841-50. PubMed ID: 231196
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic inhibition of catecholamine-stimulable cyclic AMP accumulation in murine atria.
    Brown JH
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):423-33. PubMed ID: 231610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation.
    Okumura S; Kawabe J; Yatani A; Takagi G; Lee MC; Hong C; Liu J; Takagi I; Sadoshima J; Vatner DE; Vatner SF; Ishikawa Y
    Circ Res; 2003 Aug; 93(4):364-71. PubMed ID: 12869393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Effect of cholinergic mechanisms on rat gastric mucosal cAMP.
    Ruoff HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R82. PubMed ID: 4367361
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholinergic-stimulated alkaline phosphatase secretion and phospholipid synthesis in guinea pig seminal vesicles.
    Lockwood DH; Williams-Ashman HG
    J Cell Physiol; 1971 Feb; 77(1):7-15. PubMed ID: 4323201
    [No Abstract]   [Full Text] [Related]  

  • 6. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB; Harden TK
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractoriness to muscarinic and adrenergic agonists in the rat parotid: responses of adenosine and guanosine cyclic 3', 5'-monophosphates.
    Harper JF; Brooker G
    Mol Pharmacol; 1977 Nov; 13(6):1048-59. PubMed ID: 201829
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac metabolism: cetecholamines, calcium, cyclic AMP, and substrates.
    Opie LH
    Adv Myocardiol; 1980; 1():3-20. PubMed ID: 6248937
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscarinic regulation of phosphatidylinositol turnover and cyclic nucleotide metabolism in the heart.
    Brown JH; Masters SB
    Fed Proc; 1984 Aug; 43(11):2613-7. PubMed ID: 6086410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated kidney preservation in relationship to cholinergic and adrenergic processes.
    Fonteles MC; Karow AM
    Surg Gynecol Obstet; 1975 Aug; 141(2):267-76. PubMed ID: 807979
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of isoproterenol alone and in the presence of carbachol on cAMP levels in hyperthyroid guinea pig left atria.
    MacLeod KM
    Proc West Pharmacol Soc; 1983; 26():323-7. PubMed ID: 6310630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of action of sympathetic and parasympathetic neuromediators at the level of the heart cell: use of photosensitive molecules].
    Nargeot J
    J Pharmacol; 1985; 16 Suppl 1():89-118. PubMed ID: 2863424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasympathetic control of the heart.
    Higgins CB; Vatner SF; Braunwald E
    Pharmacol Rev; 1973 Mar; 25(1):119-55. PubMed ID: 4348231
    [No Abstract]   [Full Text] [Related]  

  • 14. Salivary secretion of electrolytes.
    Schneyer LH; Young JA; Schneyer CA
    Physiol Rev; 1972 Jul; 52(3):720-77. PubMed ID: 4337927
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical mechanisms in the control of thyroid function and growth.
    Dumont JE; Boeynaems JM; Decoster C; Erneux C; Lamy F; Lecocq R; Mockel J; Unger J; Van Sande J
    Adv Cyclic Nucleotide Res; 1978; 9():723-34. PubMed ID: 208404
    [No Abstract]   [Full Text] [Related]  

  • 16. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
    Ray A; MacLeod KM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1594-601. PubMed ID: 7690405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine 3':5'-cyclic monophosphate as a mediator in the action of neurohumoral agents.
    Greengard P; McAfee DA
    Biochem Soc Symp; 1972; (36):87-102. PubMed ID: 4374952
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of intrahypothalamic injections of cholinergic and adrenergic agents on defensive behavior in cats.
    Romaniuk A; Brudzyński S; Grońska J
    Acta Physiol Pol; 1974; 25(4):297-305. PubMed ID: 4472364
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic AMP arrhythmias. Inhibition by choline esters.
    Podzuweit T
    Adv Myocardiol; 1982; 3():193-8. PubMed ID: 6302763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.
    Okoshi K; Nakayama M; Yan X; Okoshi MP; Schuldt AJ; Marchionni MA; Lorell BH
    Circulation; 2004 Aug; 110(6):713-7. PubMed ID: 15289373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.